Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008;11(2):81-87.
doi: 10.1142/S0218957708001961.

IN VITRO TRANSPLANTATION OF GENETICALLY MODIFIED CELLS TO THE TENDON SURFACE

Affiliations

IN VITRO TRANSPLANTATION OF GENETICALLY MODIFIED CELLS TO THE TENDON SURFACE

Paulus J J Couvreur et al. J Musculoskelet Res. 2008.

Abstract

The objective of this paper was to study in vitro transfection of tendon cells and adherence of transfected cells to different tendon surfaces. Achilles tendon fibroblasts from 2-month-old New Zealand white rabbits were cultured to confluence, after which the cells were transfected by an adenovirus carrying either the β-galactosidase reporter gene or the green fluorescent protein (GFP) gene at multiplicities of infection (MOIs) of 50, 100, or 500. Two days later, the cells were transplanted onto the surfaces of rabbit Achilles, peroneus brevis, flexor profundus, and extensor longus tendons. The tendons were assessed by X-gal staining after 9 days, and by GFP fluorescence at 7, 14, and 21 days. Twenty percent to 50% of the treated cells stained for β-galactosidase at an MOI of 500. The GFP-labeled cells showed nearly 100% fluorescence at an MOI of 50. No positive cells were visible in the control group. The β-galactosidase and GFP-expressing cells remained viable for as long as 3 weeks. It is possible to introduce foreign genes into rabbit tendon cells, transplant the cells onto tendon surfaces, and maintain viability of the cell/tendon construct for several weeks.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
β-galactosidase staining on tendon surface (×40). Transfected cells stain blue.
Fig. 2
Fig. 2
Roller device method.
Fig. 3
Fig. 3
Roller bank cells with GFP staining after 1, 7, and 21 days (confocal fluorescent microscopy, ×100). Transfected cells fluoresce green. A: Achilles tendon; FDP: flexor digitorum profundus tendon.
Fig. 4
Fig. 4
Hyaluronan synthase transfection as demonstrated by red blood cell (RBC) exclusion. (a) Control. Note the RBC cover tendon fibroblasts. (b) RBC exclusion in a halo around transfected cells. (c) Halo effect abolished by treatment with hyaluronidase. (All ×400.)

Similar articles

References

    1. Anderson WF. Prospects for human gene therapy. Science. 1984;226:401–409. - PubMed
    1. Bainbridge JW, Mistry AR, Thrasher AJ, Ali RR. Gene therapy for ocular angiogenesis. Clin Sci. 2003;104:561–575. - PubMed
    1. Bonadio J. Tissue engineering via local gene delivery. J Mol Med. 2000;78:303–311. - PubMed
    1. Boyer MI, Strickland JW, Engles D, Sachar K, Leversedge FJ. Flexor tendon repair and rehabilitation: State of the art in 2002. Instr Course Lect. 2003;52:137–161. - PubMed
    1. Engelhardt JF, Ye X, Doranz B, Wilson JM. Ablation of E2A in recombinant adenoviruses improves trans-gene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA. 1994;91:6196–6200. - PMC - PubMed

LinkOut - more resources